Japanese Journal of Cancer Research · 1995 · 20 citations · 16 references
MedicineGeneticsOncologyCancer GeneticsGenitourinary OncologyMolecular OncologyBladder CancerCancer GenomicsCancer Molecular PathologyMalignant NeoplasmsTumor Suppressor GenesBladder PathologyMutationSomatic Mutation ProfilingSomatic MutationsTumor Suppressor Gene AnalysisTumor Suppressor Gene DeletionsTumor Suppressor Gene LossTumor Suppressor Pathways
We examined a candidate tumor suppressor gene on chromosome 9p21, MTS1/CDK4I (multiple tumor suppressor 1/cyclin-dependent kinase 4 inhibitor), which has been found to be mutated frequently in cell lines derived from bladder carcinomas, for somatic mutations in 39 primary bladder cancers by means of SSCP (single-stranded conformational polymorphism) and DNA sequencing. Mutations were detected in two of these carcinomas; one was a 61-base deletion and the other a 1-base deletion. In both cases the homologous allele was missing, indicating that "two-hit" mutation of the MTS1 gene had taken place in these tumors. The results indicated that inactivation of the MTS1 gene is likely to be a contributing factor in some, but not the majority of, bladder cancers.
16
A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor Types
Alexander Kamb, Nelleke A. Gruis, Jane Weaver-Feldhaus et al. · Science · 1994 · 2.8K citations
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
Tsutomu Nobori, Kaoru Miura, David Wu et al. · Nature · 1994 · 1.8K citations
Germline p16 mutations in familial melanoma
Christopher J. Hussussian, Jeffery P. Struewing, Alisa M. Goldstein et al. · Nature Genetics · 1994 · 1.3K citations
Life Sciences, Genetics, Oncology +14